Skip to main content
HR 5501 116th Congress House Health Competition and antitrust Congressional oversight Department of Health and Human Services Drug safety, medical device, and laboratory regulation Executive agency funding and structure Federal officials Government employee pay, benefits, personnel management Health care costs and insurance Health care coverage and access Health care quality Health programs administration and funding Inflation and prices Licensing and registrations Manufacturing Prescription drugs Public contracts and procurement Public participation and lobbying

Affordable Drug Manufacturing Act of 2019

Introduced: December 19, 2019 Introduced by: Schakowsky, Janice D. Democratic · Illinois See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Dec 20, 2019
Referred to the Subcommittee on Health.
Dec 19, 2019
Referred to the House Committee on Energy and Commerce.
Dec 19, 2019
Introduced in House
 Plain-English summary Congressional Research Service

Affordable Drug Manufacturing Act of 2019

This bill establishes the Office of Drug Manufacturing within the Department of Health and Human Services to lower prices for, increase access to, and address shortages of prescription drugs (e.g., insulin, naloxone, and antibiotics), including by manufacturing prescription drugs and selling them at a fair price.

What's happening now December 20, 2019

Referred to the Subcommittee on Health.

 Committees of jurisdiction 2